China-based Chongqing Genrix Biopharmaceutical Co., Ltd (SHA: 688443) has announced that its investigational product, GR1802...
Swiss firm Santhera Pharmaceuticals (SWX: SANN), a leader in innovative therapies for rare diseases, has...
Biopharmaceutical company Vivatides Therapeutics has successfully completed a multi-million dollar seed round financing led by...
In a significant move to enhance the quality and accessibility of primary healthcare, the National...
Hunan FangSheng Pharmaceutical Co., Ltd. (SHA: 603998) announced today that it has reached an agreement...
Haihe Biopharma Co., Ltd. has filed a market application with Japan’s Ministry of Health, Labour...
Shenzhen-based QuantumPharm Inc., known as Xtalpi Inc. (HKG: 2228) and Korea’s leading pharmaceutical company, Dong-A...
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced that LM-302, an innovative antibody-drug conjugate (ADC) developed...
Goodrx Holdings Inc (NASDAQ: GDRX), the leading platform for medication savings in the U.S., has...
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) has unveiled its 2025 interim results, showcasing a...
China-based Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) and its subsidiary Gensun Biopharma Inc. announced...
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) reported unaudited interim results for the six...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) released its financial results for the first half...
WuXi Biologics (Cayman) Inc. (HKG: 2269), a leading global Contract Research, Development and Manufacturing Organization...
RemeGen Co., Ltd. (SHA: 688331, HKG: 9995), a China-based biotech company, announced that its novel...
Shandong Lukang Pharmaceutical Co., Ltd. (SHA: 600789) announced that its CIGB-814 immunomodulator has commenced a...
Chinese pharmaceutical company HutchMed (China) Ltd (NASDAQ: HCM, HKG: 0013) announced the completion of patient...
China-based Sino Biopharmaceutical Limited (HKG: 1177) announced its financial results for the first half of 2025....
Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced that it has received approval from...
Chongqing Zhifei Biological Co., Ltd. (SHE: 300122), based in China, announced that its Acellular Pertussis,...